7 | Pharmaceutical PreparationsIBA
02/2015
-
10/2004 |
6 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
05/2014
-
06/2008 |
4 | alpha7 Nicotinic Acetylcholine ReceptorIBA
12/2011
-
03/2009 |
3 | Glutamic Acid (Glutamate)FDA Link
01/2016
-
03/2003 |
3 | Antipsychotic Agents (Antipsychotics)IBA
02/2015
-
12/2011 |
3 | 5-HT2C Serotonin ReceptorIBA
11/2007
-
11/2006 |
2 | Proteins (Proteins, Gene)FDA Link
01/2017
-
06/2014 |
2 | LigandsIBA
04/2013
-
07/2007 |
2 | Cholinergic Agents (Cholinergics)IBA
07/2009
-
08/2007 |
2 | 1,2,3,4,8,9,10,10a- octahydro- 7bH- cyclopenta(b)(1,4)diazepino(6,7,1hj)indoleIBA
06/2007
-
11/2006 |
2 | Serotonin (5 Hydroxytryptamine)IBA
02/2006
-
12/2002 |
1 | MethyltransferasesIBA
03/2021 |
1 | Histones (Histone)IBA
03/2021 |
1 | Lysine (L-Lysine)FDA Link
03/2021 |
1 | Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017 |
1 | Biomarkers (Surrogate Marker)IBA
01/2017 |
1 | DNA-Binding Proteins (DNA Binding Protein)IBA
01/2017 |
1 | Aminobutyrates (Aminobutyric Acid)IBA
01/2017 |
1 | Protein AggregatesIBA
01/2017 |
1 | Dizocilpine Maleate (Dizocilpine)IBA
03/2016 |
1 | 5- amino- 3,4- dimethyl- N- (4- ((trifluoromethyl)sulfonyl)benzyl)thieno(2,3- c)pyridazine- 6- carboxamideIBA
03/2016 |
1 | Hypnotics and Sedatives (Sedatives)IBA
03/2016 |
1 | Clozapine (Clozaril)FDA LinkGeneric
03/2016 |
1 | Glutamate Receptors (Glutamate Receptor)IBA
03/2016 |
1 | N-Methylaspartate (NMDA)IBA
03/2016 |
1 | 4-Aminopyridine (4 Aminopyridine)FDA Link
01/2016 |
1 | Alanine (L-Alanine)FDA Link
03/2015 |
1 | Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
02/2015 |
1 | Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2014 |
1 | Mutant Proteins (Protein, Mutant)IBA
06/2014 |
1 | ceramide glucosyltransferaseIBA
06/2014 |
1 | GlycosphingolipidsIBA
06/2014 |
1 | SynucleinsIBA
06/2014 |
1 | Leucine (L-Leucine)FDA Link
02/2014 |
1 | Amino AcidsFDA Link
02/2014 |
1 | IsotopesIBA
02/2014 |
1 | PhosphopeptidesIBA
02/2014 |
1 | Phosphotransferases (Kinase)IBA
02/2014 |
1 | alpha-SynucleinIBA
01/2013 |
1 | PrionsIBA
01/2013 |
1 | vabicaserinIBA
01/2012 |
1 | 1- (6- (4- fluorophenyl)pyridin- 3- yl)- 3- (4- piperidin- 1- ylbutyl)ureaIBA
12/2011 |
1 | N,N'-dibenzhydrylethane-1,2-diamine dihydrochlorideIBA
07/2011 |
1 | metabotropic glutamate receptor 7IBA
07/2011 |
1 | 5-morpholin-4-ylpentanoic acid (4-pyridin-3-ylphenyl)amideIBA
05/2009 |
1 | Acid Sensing Ion ChannelsIBA
09/2008 |
1 | DiureticsIBA
09/2008 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
09/2008 |
1 | Amiloride (Midamor)FDA LinkGeneric
09/2008 |
1 | Ligand-Gated Ion ChannelsIBA
06/2008 |
1 | ImmunophilinsIBA
07/2007 |
1 | Antidepressive Agents (Antidepressants)IBA
06/2007 |
1 | Analgesics (Analgesic Drugs)IBA
05/2007 |
1 | Cyclic NucleotidesIBA
05/2007 |
1 | Loperamide (Imodium)FDA LinkGeneric
05/2007 |
1 | Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA
05/2007 |
1 | Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
03/2006 |
1 | Appetite Depressants (Anorectics)IBA
02/2006 |
1 | Aripiprazole (Abilify)FDA Link
02/2006 |
1 | Dopamine (Intropin)FDA LinkGeneric
02/2006 |
1 | Excitatory Amino AcidsIBA
02/2006 |
1 | Carrier Proteins (Binding Protein)IBA
02/2006 |
1 | 3- aminotricyclo(2.2.1.02.6)heptane- 1,3- dicarboxylic acidIBA
06/2005 |
1 | benzyloxyaspartate (TBOA)IBA
06/2005 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
11/2004 |
1 | Superoxide DismutaseIBA
03/2003 |
1 | RiluzoleFDA LinkGeneric
03/2003 |